ClinicalTrials.Veeva

Menu

A Meta-analysis of Drug Eluting Stents Versus Bare Metal Stents in Saphenous Vein Graft Disease

C

Catholic University of the Sacred Heart

Status

Completed

Conditions

Saphenous Vein Graft Disease

Treatments

Device: bare metal stent
Device: drug eluting stent

Study type

Observational

Funder types

Other

Identifiers

NCT01036048
N28LBCF80-07

Details and patient eligibility

About

A meta-analysis to compare outcomes of drug eluting stents (DES) versus bare metal stent (BMS) in saphenous vein graft (SVG) disease.

Full description

To compare outcomes (death, myocardial infarction, target vessel revascularization) of drug eluting stent versus bare metal stent in saphenous vein graft disease.

Enrollment

5,806 patients

Sex

All

Volunteers

No Healthy Volunteers

Inclusion criteria

  • CABG disease
  • randomized studies
  • not randomized studies

Exclusion criteria

  • studies reporting composite and not single endpoints, duplicate reporting

Trial design

5,806 participants in 1 patient group

cabg disease
Description:
pts with saphenous vein graft disease
Treatment:
Device: drug eluting stent
Device: bare metal stent

Trial contacts and locations

0

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems